Clinical trial
Evaluation of the Effects of Carperitide in Patients With Congestive Heart…
NCT00259038 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00259038 |
|---|---|
| Title | Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure |
| Official title | A Phase II, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide in Subjects With Congestive Heart Failure |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Heart Decompensation, Left Ventricular Failure, Myocardiopathies, Systolic or Diastolic Left Ventricular Dysfunction |
| Intervention type | Drug |
| Interventions | Carperitide, Placebo |
| Enrollment | 162 |
| Start date | Jan 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Nov 29, 2005 |
| Last update posted | Nov 8, 2016 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: